Minfeng Chen
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
Papers in
-
- Prostate Cancer Treatment and Research 10
- Ferroptosis and cancer prognosis 8
- Prostate Cancer Diagnosis and Treatment 6
- Co-authors
- Dongmei Zhang (24 shared papers)Wen‐Cai Ye (21 shared papers)Lijuan Deng (10 shared papers)Xiongbing Zu (22 shared papers)Zhe‐Sheng Chen (4 shared papers)Maohua Huang (13 shared papers)Jinbo Chen (9 shared papers)Lin Qi (20 shared papers)
- Journals
- BMC Cancer (4 papers)European Journal of Nuclear Medicine and Molecular Imaging (4 papers)Orphanet Journal of Rare Diseases (3 papers)Cancer Letters (3 papers)Scientific Reports (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Minfeng Chen
80 papers receiving 2.2k citations
Minfeng Chen's Hit Papers
Peers
Comparison fields: 5 of 113
- Cancer Research 607
- Molecular Biology 1.3k
- Oncology 465
- Pharmacology 120
- Pulmonary and Respiratory Medicine 439
Countries citing papers authored by Minfeng Chen
This map shows the geographic impact of Minfeng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minfeng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minfeng Chen more than expected).
Fields of papers citing papers by Minfeng Chen
This network shows the impact of papers produced by Minfeng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minfeng Chen. The network helps show where Minfeng Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Minfeng Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | m6A modification: recent advances, anticancer targeted drug discovery and beyond Hit paper breakdown → | 2022 | 252 |
| 2 | Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer Hit paper breakdown → | 2021 | 250 |
| 3 | 2013 | 190 | |
| 4 | 2019 | 115 | |
| 5 | 2022 | 101 | |
| 6 | 2019 | 82 | |
| 7 | 2017 | 59 | |
| 8 | 2010 | 51 | |
| 9 | 2014 | 49 | |
| 10 | 2022 | 48 | |
| 11 | 2023 | 46 | |
| 12 | 2023 | 44 | |
| 13 | 2015 | 41 | |
| 14 | 2023 | 38 | |
| 15 | 2016 | 38 | |
| 16 | 2016 | 36 | |
| 17 | 2021 | 34 | |
| 18 | 2019 | 33 | |
| 19 | 2020 | 32 | |
| 20 | 2023 | 32 |
About Minfeng Chen
Minfeng Chen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Surgery, having authored 85 papers that have together received 2.2k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (16 papers), Urinary and Genital Oncology Studies (10 papers), Prostate Cancer Treatment and Research (10 papers), Cancer Immunotherapy and Biomarkers (8 papers), Ferroptosis and cancer prognosis (8 papers), Cancer-related molecular mechanisms research (8 papers), Cancer, Lipids, and Metabolism (7 papers) and Prostate Cancer Diagnosis and Treatment (6 papers). The work is most often cited by research in Cancer Research (607 citations), Molecular Biology (1.3k citations), Oncology (465 citations), Pharmacology (120 citations) and Pulmonary and Respiratory Medicine (439 citations). Minfeng Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Dongmei Zhang, Wen‐Cai Ye, Lijuan Deng, Xiongbing Zu, Zhe‐Sheng Chen, Maohua Huang, Jinbo Chen, Lin Qi, Huihui Zhang and Ming Qi. Their work appears in journals such as BMC Cancer, European Journal of Nuclear Medicine and Molecular Imaging, Orphanet Journal of Rare Diseases, Cancer Letters and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.